Effects of prostaglandin E2 production on LPS-induced reduction in wheel-running activity in mice

Japanese Journal of Physical Fitness and Sports Medicine

Volumn 55, Issue SUPPL., 2006, Pages 15-18

  Yano, Hiromi ^a   Fujinami, Yuki ^a   Matsumoto, Takashi ^a   Shiva, Daisuke ^a  

^a KAWASAKI UNIVERSITY OF MEDICAL WELFARE   (Japan)

Author keywords

C3H HeJ mouse; Indomethacin; Lipopolysaccharide; Sickness behavior

Indexed keywords

EID: 33751290745     PISSN: 0039906X     EISSN: None     Source Type: Journal    
DOI: 10.7600/jspfsm.55.s15     Document Type: Conference Paper

References (11)

1. Ilback, N. G., Crawford, D. J., Neufeld, H. A., & Friman, G. Does exercise stress alter susceptibility to bacterial infections? Ups. J. Med. Sci., (1991), 96, 63-68.
2. Davis, J. M., Weaver, J. A., Kohut, M. L., Colbert, L. H., Ghaffar, A., & Mayer, E. P. Immune system activation and fatigue during treadmill running: role of interferon. Med. Sci. Sports Exerc., (1997), 30, 863-868.
3. Kent, S., Kelley, K. W., & Dantzer, R. Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist. Neurosci. Lett, (1992), 145, 83-86.
4. Johnson, R. W., Gheusi, G., Segreti, S., Dantzer, R., & Kelley, K. W. C3H/HeJ mice are refractory to lipopolysaccharide in the brain. Brain Res., (1997), 752, 219-226.
5. Tollner, B., Roth, J., Storr, B., Martin, D., Voigt, K., & Zeisberger, E. The role of tumor necrosis factor (TNF) in the febrile and metabolic responses of rats to intraperitoneal injection of a high dose of lipopolysaccharide. Pflugers Arch., (2000), 440, 925-932.
6. Lipsky, P. E. Specific COX-2 inhibitors in arthritis, oncology, and beyond: where is the science headed? J. Rheumatol., (1999), 26, Suppl 56, 25-30.
7. Portanova, J. P., Zhang, Y., Anderson, G. D., Hauser, S. D., Masferrer, J. L., Seibert, K., Gregory, S. A., & Isakson, P. C. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med., (1996), 184, 889-891.
8. Segreti, J., Gheusi, G., Dantzer, R., Kelley, K. W., & Johnson, R. W. Defect in interleukin-1β secretion prevents sickness behavior in C3H/HeJ mice. Physiol. Behav., (1997), 61, 873-878.
9. Moncada, S., Palmer, R. M. J., & Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., (1991), 43, 109-141.
10. Tracey, W. R., Tse, J., & Carter, G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J. Pharmacol. Exp. Ther., (1995), 272, 1011-1015.
11. Aggarwal, B. B. Nuclear factor-κB: the enemy within. Cancer Cell, (2004), 6, 203-208.